Clinical significance of hepatitis B virus large protein detection in clinical diagnosis and treatment
-
摘要: 目的:对乙肝病毒血清学标志物HBV-M(包括HBsAg、HBsAb、HBeAg、HBeAb、HBcAb),乙肝病毒外膜大蛋白(HBV-Lp),乙肝病毒前S1抗原(HBV-Pres1)和乙肝病毒脱氧核糖核酸(HBV-DNA)联合检测结果进行比较,观察乙肝病毒外膜大蛋白(HBV-Lp)检测在临床诊断治疗乙肝中的应用价值,寻求比现有常规检测更敏感、更准确的实验室乙肝检测方法。方法:将感染科461例标本分成5组进行比较分析:78例乙肝表面抗原(吸收度A值<1)阴性血清标本为A对照组;9例HBsAg弱阳性(吸收度A值为1~2)血清标本为B组;201例HBsAg阳性(吸收度A值>2)且HBV-DNA含量<5×102IU/ml的血清标本为C组;133例HBsAg阳性(吸收度A值>2)且HBV-DNA含量5×102~5×105IU/ml的血清标本为D组;40例HBsAg阳性(吸收度A值>2)且HBV-DNA含量>5×105IU/ml的血清标本为E组。用酶联免疫吸附法检测HBV-M,HBV-Lp和HBV-Pres1,PCR-荧光探针法定量检测HBV-DNA。结果:A组和B组未见Pre-S1和HBV-LP结果异常。C、D、E组中HBeAg的阳性率依次为0.99%,6.02%,77.50%;Pre-S1的阳性率依次为29.35%,42.86%,90.00%;HBV-LP的阳性率依次为38.31%,55.64%,95.00%,HBV-LP、HBeAg和Pre-S1的阳性率可能性均随着HBV-DNA含量的增加而增大(P<0.05)。C、D、E组中HBeAg、Pre-S1和HBV-LP的检出率分别为10.96%,40.64%,50.53%,HBV-LP的检出率明显高于HBeAg和Pre-S1的检出率(P<0.05)。通过对相同HBV-DNA含量组的HBV-LP、HBeAg和Pre-S1阳性率进行统计学t检验比较,可以看出HBV-LP的检出率明显高于HBeAg和Pre-S1的检出率(P<0.05)。C、D、E组中HBV-LP的平均吸收度A值依次为2.53,5.35,13.93。HBV-DNA含量的增加伴随着有HBV-LP浓度的增加(P<0.05)。结论:HBV-LP检测比HBeAg和Pre-S1检测敏感性强,被检出的可能性更大,漏检的可能性更小。HBV-LP检测与HBV-DNA检测呈正相关性,HBV-LP在HBsAg阳性而HBV-DNA检测阴性时有理想的检出率,可能会对乙型肝炎诊断治疗进行补充作用。Abstract: Objective:By comparing the result of serological markers for hepatitis B virus HBV-M(including HBsAg,HBsAb,HBeAg,HBeAb,HBcAb),hepatitis B virus large outer membrane protein(HBV-Lp),former S1 antigen hepatitis B virus(HBV Pres1)and hepatitis B virus DNA(HBV DNA),observe the value of hepatitis B virus large outer membrane protein(HBV-Lp)in the clinical diagnosis and treatment of viral hepatitis B,to seek a more sensitive and accurate method of laboratory testing than the existing conventional detection.Method:The 461 specimens from the Infectious Disease Department of the hospital were divided into five groups for comparison and analysis:78 cases of serum specimens with HBsAg negative(absorbance A value is<1)for control group A;9 cases of serum specimens with HBsAg weak positive(absorbance A value is 1-2)were in group B;201 cases of serum specimens with HBsAg positive(absorbance A value is>2)and HBV-DNA content<5×102IU/ml were in group C;133 cases of serum specimens with HBsAg positive(absorbance A value is>2)and HBV-DNA content 5×102-5×105IU/ml were in group D;40 serum samples with HBsAg positive(absorbance A value is>2)and HBV-DNA content>5×105IU/ml were group E.HBV-M,HBV-Lp and HBV-Pres1 were detected by enzyme-linked immunosorbent assay,and HBV-DNA was quantitatively detected by PCR-fluorescence probe method.Result:No abnormalities of Pre-S1 and HBV-LP were found in groups A and B.The positive rates of HBeAg in the C,D and E groups were 0.99%,6.02%,and 77.50%,respectively;the positive rates of Pre-S1 were 29.35%,42.86%,and 90.00%,respectively;the positive rate of HBV-LP was 38.31%,55.64%,95.00%,The positive possibility of HBV-LP,HBeAg and Pre-S1 increased with the increase of HBV-DNA content(P<0.05).The detection rates of HBeAg,Pre-S1,and HBV-LP in the C,D,and E groups were 10.96%,40.64%,and 50.53%,respectively.The detection rate of HBV-LP was significantly higher than that of HBeAg and Pre-S1(P<0.05).By comparing the HBV-LP,HBeAg,and Pre-S1 positive rates of the same HBV-DNA content group by statistical t test,it can be seen that the detection rate of HBV-LP is significantly higher than the detection rate of HBeAg and Pre-S1(P<0.05).The average absorbance A values of HBV-LP in the C,D,and E groups were 2.53,5.35,and 13.93,respectively.The increase in HBV-DNA content was accompanied by an increase in HBV-LP concentrations(P<0.05).Conclusion:HBV-LP has a more sensitive and higher detection rate than HBeAg and Pre-s1.The detection of HBV-LP was positively correlated with the detection of HBV-DNA,HBV-LP had an idealdetection rate when HBsAg was positive and HBV-DNA was negative,which may complement the diagnosis and treatment of hepatitis B.
-
-
[1] 王金霞,赵玉良,马景臣.乙型肝炎病毒基因型研究进展[J].实用预防医学杂志,2017,24(12):1539-1542.
[2] Churin Y,Roderfeld M,Roeb E.Hepatitis B virus large surface protein:function and fame[J].Hepatobililiary Surg Nutr,2015,4:1-10.
[3] Li YW,Yang FC,Lu HQ,et al.Hepatocellular carcinoma and hepatitis B surface protein[J].World Gastroenterol,2016,22:1943-1952.
[4] Hartmann-Stühler C,Prange R.Hepatitis B Virus Large Envelope Protein Interacts with γ2-Adaptin,a Clathrin Adaptor-Related Protein[J].J Virol,2001,75:5343-5351.
[5] 谢冬英,林炳亮,徐启桓,等.基线HBeAg水平对HBeAg阳性慢性乙型肝炎阿德福韦酯治疗的预测价值[J].中华临床医师杂志,2010,4(8):1251-1255.
[6] 李俊茜,庄辉,杜珩,等.乙型肝炎e抗原阴性慢性乙型肝炎患者病毒基因型及丙氨酸转移酶水平分析[J].中华肝病杂志,2005,13(7):491-493.
[7] Alexopoulou A,Karayiannis P.HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection[J].World J Gastroenterol,2014,20:7644-7652.
[8] Toita R,Kawano T,Kang JH,et al.Applications of human hepatitis B virus preS domain in bio-and nanotechnology[J].World J Gastroenterol,2015,21:7400-7411.
[9] Selzer L,Zlotnick A.Assembly and Release of Hepatitis B Virus[J].Cold Spring Harb Perspect Med,2015,5:a021394.
[10] 程振波,谭黎明,李建英,等.乙型肝炎病毒感染者血清HBV-LP检测意义及其与Pre S1抗原、HBV DNA之间关系的研究[J].实用预防医学,2016,23(4):487-489.
[11] 候玲,徐晚枫.乙型肝炎(HBV)感染临床治愈后的长期预后[J].日本医学介绍,2004,25(11):510-510.
[12] 庄辉.HBsAg消失或血清学转换是慢性乙型肝炎理想的治疗终点[J].中国病毒病杂志,2017,7(5):324-327.
[13] Jiang WC.Analysis on synchronous test of HBV-M and HBV-DNA in 650 patients with chronic hepatitis[J].Chin J Gastroenterol Hepatol,2013,22:141-143.
-
计量
- 文章访问数: 405
- PDF下载数: 759
- 施引文献: 0